Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder

Neuropsychobiology

Volumn 50, Issue 3, 2004, Pages 235-238

  Tsai, Shih Jen ^a,f   Hong, Chen Jee ^a   Yu, Younger W Y ^b   Chen, Tai Jui ^c,d   Wang, Ying Chieh ^e   Lin, Wen Kuo ^e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Yu's Psychiatric Clinic   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

^e YULI VETERANS HOSPITAL   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Major depressive disorder; Polymorphism; Selective serotonin reuptake inhibitors; Serotonin 1B receptor; Suicide; Treatment response

Indexed keywords

FLUOXETINE; SEROTONIN 1B RECEPTOR;

ADULT; ALLELE; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SUICIDE ATTEMPT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT1B; SUICIDE, ATTEMPTED;

EID: 4644264502     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079977     Document Type: Article

References (23)

1. Meltzer H: Serotonergic dysfunction in depression. Br J Psychiatry Suppl 1989;8:25-31.
2. Risch SC, Nemeroff CB: Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry 1992;53(suppl):3-7.
3. Blier P, de Montigny C, Chaput Y: A role for the serotonin system in the mechanism of action of antidepressant treatments: Preclinical evidence. J Clin Psychiatry 1990;51(suppl):14-20.
4. Owens MJ: Molecular and cellular mechanisms of antidepressant drugs. Depress Anxiety 1996;4:153-159.
5. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
6. Hamblin MW, Metcalf MA, McGuffin RW, Karpells S: Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: A homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity. Biochem Biophys Res Commun 1992;184:752-759.
7. Sun HF, Chang YT, Fann CS, Chang CJ, Chen YH, Hsu YP, Yu WY, Cheng AT: Association study of novel human serotonin 5-HT(1B) polymorphisms with alcohol dependence in Taiwanese Han. Biol Psychiatry 2002;51:896-901.
8. Brunner D, Hen R: Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann NY Acad Sci 1997;836:81-105.
9. Bonhomme N, Esposito E: Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review. J Clin Psychopharmacol 1998;18:447-454.
10. Malagie I, David DJ, Jolliet P, Hen R, Bourin M, Gardier AM: Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knockout mice. Eur J Pharmacol 2002;443:99-104.
11. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
12. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ: Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders symptomatology and antidepressant response. Am J Med Genet 2003;123B:19-22.
13. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ: Association study of the interleukin-1beta (C-511T) genetic polymorphism with major depressive disorder associated symptomatology and antidepressant response. Neuropsychopharmacology 2003;28:1182-1185.
14. Yu YW, Chen TJ, Wang YC, Liou YJ, Hong CJ, Tsai SJ: Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 2003;47:37-140.
15. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ: Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002;7:1115-1119.
16. Huang YY, Grailhe R, Arango V, Hen R, Mann JJ: Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 1999;21:238-246.
17. Fehr C, Grintschuk N, Szegedi A, Anghelescu I, Klawe C, Singer P, Hiemke C, Dahmen N: The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res 2000;97:1-10.
18. Huang YY, Oquendo MA, Friedman JM, Greenhill LL, Brodsky B, Malone KM, Khait V, Mann JJ: Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 2003;28:163-169.
19. Rujescu D, Giegling I, Sato T, Moller HJ: Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior. Am J Med Genet 2003;116B:69-71.
20. New AS, Gelernter J, Goodman M, Mitropoulou V, Koenigsberg H, Silverman J, Siever LJ: Suicide impulsive aggression and HTR1B genotype. Biol Psychiatry 2001;50:62-65.
21. Lappalainen J, Long JC, Eggert M, Ozaki N, Robin RW, Brown GL, Naukkarinen H, Virkkunen M, Linnoila M, Goldman D: Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 1998;55:989-994.
22. Briley M, Moret C: Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 1993;16:387-400.
23. Kiel S, Bruss M, Bonisch H, Gothert M: Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: Changes in ligand binding G-protein coupling and second messenger formation. Pharmacogenetics 2000;10:655-666.